UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 245

Sortiert nach

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohort

Cancer, 2016-12, Vol.122 (23), p.3673-3681

2016

Volltextzugriff (PDF)

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3275-3283

2014

Volltextzugriff (PDF)

Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?

American journal of obstetrics and gynecology, 2011-01, Vol.204 (1), p.19.e1-19.e6

2011

Volltextzugriff (PDF)

Parent decision‐making around the genetic testing of children for germline TP53 mutations

Cancer, 2015-01, Vol.121 (2), p.286-293

2015

Volltextzugriff (PDF)

Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort

JAMA oncology, 2017-12, Vol.3 (12), p.1640

2017

Volltextzugriff (PDF)

Challenges related to developing serum-based biomarkers for early ovarian cancer detection

Cancer prevention research (Philadelphia, Pa.), 2011-03, Vol.4 (3), p.303-306

2011

Volltextzugriff (PDF)

Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype

Endocrine-related cancer, 2010-06, Vol.17 (2), p.R109-R121

2010

Volltextzugriff (PDF)

A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseline Characteristics: A Gynecologic Oncology Group Study

Cancer epidemiology, biomarkers & prevention, 2008-03, Vol.17 (3), p.594-604

2008

Volltextzugriff (PDF)

Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma

PloS one, 2009-03, Vol.4 (3), p.e4812-e4812

2009

Volltextzugriff (PDF)

Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women

The Lancet. Healthy longevity, 2022-01, Vol.3 (1), p.e54-e66

2022

Volltextzugriff (PDF)

Cancer incidence, patterns, and genotype–phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study

The lancet oncology, 2021-12, Vol.22 (12), p.1787-1798

2021

Volltextzugriff (PDF)

Awareness of Cancer Susceptibility Genetic Testing: The 2000, 2005, and 2010 National Health Interview Surveys

American journal of preventive medicine, 2014-05, Vol.46 (5), p.440-448

2014

Volltextzugriff (PDF)

Release of reclassified VUS results of now deceased patients to family members: Practices and opinions

Journal of genetic counseling, 2024-01

2024

Volltextzugriff (PDF)

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

JAMA : the journal of the American Medical Association, 2012-01, Vol.307 (4), p.382

2012

Volltextzugriff (PDF)

Comparing Breast Cancer Risk Assessment Models

JNCI : Journal of the National Cancer Institute, 2010-05, Vol.102 (10), p.665-668

2010

Volltextzugriff (PDF)

Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants

Human mutation, 2021-03, Vol.42 (3), p.223-236

2021

Volltextzugriff (PDF)

Familial testicular germ cell tumours

Best Practice & Research Clinical Endocrinology & Metabolism, 2010-06, Vol.24 (3), p.503-513

2010

Volltextzugriff (PDF)

Physical Activity and Colon Cancer Risk among Women in the California Teachers Study

Cancer epidemiology, biomarkers & prevention, 2007-03, Vol.16 (3), p.517-525

2007

Volltextzugriff (PDF)

Germline TP53 variants and susceptibility to osteosarcoma

JNCI : Journal of the National Cancer Institute, 2015-07, Vol.107 (7), p.1

2015

Volltextzugriff (PDF)

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

Clinical cancer research, 2017-07, Vol.23 (14), p.3628-3637

2017

Volltextzugriff (PDF)

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

Clinical cancer research, 2015-02, Vol.21 (3), p.652-657

2015

Volltextzugriff (PDF)

Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts

Cancer research (Chicago, Ill.), 2020-01, Vol.80 (2), p.354-360

2020

Volltextzugriff (PDF)

Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy

Breast cancer research and treatment, 2022-07, Vol.194 (2), p.393-401

2022

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohort

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199

Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?

Parent decision‐making around the genetic testing of children for germline TP53 mutations

Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort

Challenges related to developing serum-based biomarkers for early ovarian cancer detection

Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype

A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseline Characteristics: A Gynecologic Oncology Group Study

Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma

Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women

Cancer incidence, patterns, and genotype–phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study

Awareness of Cancer Susceptibility Genetic Testing: The 2000, 2005, and 2010 National Health Interview Surveys

Release of reclassified VUS results of now deceased patients to family members: Practices and opinions

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

Comparing Breast Cancer Risk Assessment Models

Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants

Familial testicular germ cell tumours

Physical Activity and Colon Cancer Risk among Women in the California Teachers Study

Germline TP53 variants and susceptibility to osteosarcoma

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts

Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

Suchergebnisse filtern